4. Dental Disease and Systemic Inflammation
Periodontitis does not stay in the mouth—it drives chronic inflammation and bacterial translocation that reach the whole body, from heart to gut.
Dental Disease Beyond the Mouth – A Systemic Inflammatory Driver
Periodontitis is not just a dental problem. It is a chronic inflammatory condition with whole-body consequences [144].
In 1900, a British physician named William Hunter delivered a lecture to the Medical Society of London in which he proposed that a range of systemic diseases – anaemia, nephritis, and various ill-defined chronic conditions – were caused by septic foci in the mouth: infected teeth, abscessed roots, and bacteria escaping the gum line into circulation. He called it the focal infection theory. The argument spread rapidly and was taken to a logical – and devastating – extreme: if oral bacteria caused systemic disease, the solution was to remove the teeth. In the 1910s and 1920s, extraction of all teeth became a legitimate medical treatment for conditions ranging from arthritis to psychiatric illness. Hundreds of thousands of healthy teeth were removed from patients who saw no benefit. The theory was eventually discredited. Hunter was largely forgotten. What has since been validated, with considerably more precision, is that he was pointing at a real connection. Periodontal disease is associated with elevated systemic inflammatory markers, cardiovascular events, adverse pregnancy outcomes, and diabetic dysregulation through mechanisms involving both bacteraemia and inflammatory cytokine release. The oral-systemic axis that Hunter proposed exists. The intervention – mass extraction – was wrong. The microbiome science of the twenty-first century is, in a sense, returning to Hunter's question with tools he could not have imagined.
The connection between periodontal disease and systemic conditions has a documented clinical history extending back to 1900, when William Hunter proposed his focal infection theory: that oral bacteria were a primary source of systemic disease, particularly rheumatic conditions and neurological disorders. Hunter's theory was influential for decades but overclaimed – it led to mass extraction of teeth as a preventive measure, a practice later discredited. The concept was correct in direction but wrong in scope and mechanism. [254] The modern revision of Hunter's insight came through epidemiological studies beginning in the 1990s. A series of prospective cohort studies – including the Nurses' Health Study and the Health Professionals Follow-up Study at Harvard – found associations between periodontal disease severity and risk of cardiovascular disease, type 2 diabetes, and adverse pregnancy outcomes. The associations were modest in effect size but consistent across populations and adjustment for confounders. [255] The microbiota mechanism involves two pathways. Locally, periodontal inflammation creates a subgingival environment in which gram-negative anaerobes produce lipopolysaccharide, which is continuously translocated into the bloodstream from the inflamed periodontal pocket, contributing to systemic low-grade endotoxemia. Systemically, specific periodontal pathogens – P. gingivalis, Tannerella forsythia, Treponema denticola – have been detected in atherosclerotic plaques, liver tissue, and placenta, suggesting hematogenous dissemination rather than merely local inflammation. [144] For the gut specifically, the periodontitis-associated inflammatory state creates conditions – elevated systemic LPS, altered bile acid signaling, modified mucosal immune tone – that can perturb gut microbial ecology through the immune system rather than through direct bacterial seeding. Periodontal treatment in randomized trials has been shown to reduce systemic inflammatory markers including CRP and IL-6, with some evidence of parallel improvement in gut microbiota composition.
Dental disease encompasses a spectrum from enamel caries (tooth decay) through gingivitis (gingival inflammation) to periodontitis (destruction of the tooth-supporting structures including bone). While caries and gingivitis are common and often self-limiting with improved hygiene, periodontitis represents a chronic dysbiotic infection of the periodontal pocket – the space between the tooth root and the surrounding bone – that drives persistent systemic immune activation [254].
Periodontitis affects approximately 10 to 15 percent of adults in severe form and up to 50 percent in moderate form in most populations. It is driven by a dysbiotic subgingival biofilm where anaerobic keystone pathogens – particularly Porphyromonas gingivalis – produce virulence factors that subvert host immune defences, enabling the biofilm to persist and expand despite immune activity.
The systemic consequences of periodontitis arise through two primary mechanisms. First, the inflamed gingival tissue in periodontitis patients is chronically hyperaemic and highly permeable to bacterial translocation. The total surface area of inflamed periodontal tissue in a patient with generalised severe periodontitis can reach several square centimetres – representing a clinically significant chronically disrupted epithelial barrier and a sustained portal for bacterial translocation. Bacteraemia occurs repeatedly with chewing, brushing, and spontaneously from inflamed tissue.
Second, the immune response to periodontal infection generates systemic inflammatory mediators – interleukins, tumour necrosis factor, prostaglandins, reactive oxygen species – that enter the circulation and influence distant tissues. This chronic low-grade systemic inflammation is the mechanistic bridge connecting periodontitis to cardiovascular disease, type 2 diabetes worsening, adverse pregnancy outcomes, rheumatoid arthritis activity, and other systemic conditions.
The bidirectionality of this relationship is clinically significant. Systemic diseases that impair immune function, alter vascular supply, or change salivary composition (poorly controlled diabetes, HIV, certain medications) worsen periodontal disease. Conversely, periodontal treatment that reduces gingival inflammation and bacterial load improves systemic inflammatory markers, HbA1c in diabetic patients, and endothelial function in cardiovascular patients.
Gut microbiota connection: Periodontal pathogens, particularly Fusobacterium nucleatum and Porphyromonas gingivalis, are detected in gut and liver samples of patients with inflammatory bowel disease, colorectal cancer, and metabolic dysfunction-associated steatotic liver disease[G] (MASLD, formerly NAFLD) at significantly higher frequencies than in healthy controls. Whether these oral-gut translocations are causal contributors or markers of shared dysbiotic susceptibility is an active research question, but the mechanistic links are increasingly well-characterised.
From a microbiota recovery perspective, untreated periodontitis represents a persistent source of oral pathobiont inoculation to the gut that cannot be fully addressed through dietary or systemic interventions alone. Resolution of periodontal disease is therefore part of comprehensive microbiota-supportive care.
Managing Dental Disease in Microbiota-Focused Clinical Care
Dental and periodontal assessment is recommended as a baseline component of microbiota-focused clinical care, particularly for patients undergoing FMT or extended microbiota recovery programmes. Identifying and treating active dental disease removes a persistent inflammatory and pathobiont source.
Professional periodontal treatment – scaling and root planing – is the cornerstone of periodontitis management. It mechanically disrupts and removes the subgingival biofilm and calculus that home hygiene cannot reach, reduces pocket depth, and resolves gingival inflammation. Studies show that effective periodontal treatment reduces systemic inflammatory markers (CRP, IL-6) within weeks of treatment.
Maintenance periodontal care every three to four months is standard for patients with treated moderate to severe periodontitis. Without regular professional removal of re-accumulating subgingival biofilm, periodontitis recurs within months. Twice-yearly maintenance is the minimum for patients with a history of periodontal disease.
Caries management is addressed alongside periodontal care. Active carious lesions harbour high concentrations of acid-producing bacteria that contribute to oral dysbiosis. Restoring carious teeth removes these microbial reservoirs and eliminates the ecological niches they provide.
Systemic conditions that worsen periodontal disease – particularly poorly controlled diabetes – are managed in coordination with medical care. Improving glycaemic control reduces gingival inflammation and periodontal disease severity; improving periodontal health modestly improves glycaemic control. This bidirectional clinical relationship makes joint dental-medical management optimal.
Smoking cessation is the highest-impact lifestyle intervention for periodontal disease after professional treatment. Smoking impairs gingival blood flow, suppresses local immune responses, and creates a hypoxic oral environment favouring periodontal pathogens. The risk of periodontitis in smokers is three to six times that of non-smokers; cessation substantially reduces recurrence after treatment.
Nutritional support for periodontal health includes adequate vitamin C (essential for collagen synthesis and gingival integrity), vitamin D and calcium (bone support), and anti-inflammatory dietary patterns. Severe vitamin C deficiency produces scurvy – historically the most dramatic example of nutritional periodontal disease – but subclinical deficiency also impairs gingival healing and collagen remodelling.
Microbiota Effects
- Periodontitis maintains a chronically dysbiotic oral environment that provides persistent pathobiont inoculation to the gut through daily saliva swallowing, contributing to intestinal dysbiosis that cannot be fully corrected while dental disease remains active [254].
- Porphyromonas gingivalis and Fusobacterium nucleatum translocate from the oral cavity to the gut and distant organs via bacteraemia and saliva swallowing, with documented roles in intestinal inflammation, colorectal carcinogenesis, and liver pathology [144].
- Systemic inflammation from periodontitis (elevated CRP, IL-6, TNF-α) increases intestinal permeability through cytokine-mediated disruption of tight junction[G] proteins, creating a secondary pathway by which oral disease amplifies gut dysbiosis.
- Periodontal treatment that reduces gingival inflammation is associated with measurable improvements in systemic inflammatory markers and in some studies with partial restoration of a more commensal-dominant oral microbiome – reducing the pathobiont load delivered to the gut daily.
- Poorly controlled diabetes and periodontitis form a bidirectional dysbiotic loop: hyperglycaemia worsens oral dysbiosis and periodontal inflammation, while periodontal inflammation worsens glycaemic control through systemic cytokine-mediated insulin resistance.
- Restoration of periodontal health as part of comprehensive microbiota care reduces the chronic oral inflammatory burden, supporting a less pro-inflammatory systemic environment conducive to gut microbiota recovery and FMT engraftment[G].
Patient Guidance
- Attend a dental and periodontal assessment at the start of your microbiota recovery programme.
- If periodontitis is diagnosed, complete professional periodontal treatment (scaling and root planing) before or alongside FMT.
- Maintain three to four monthly professional maintenance appointments if you have a history of periodontal disease.
- Brush twice daily, clean between teeth daily, and clean the tongue to maintain oral hygiene between professional visits.
- If you smoke, treat cessation as a priority for both oral and gut microbiota health.
- Optimise glycaemic control if you have diabetes – improved blood sugar reduces gingival inflammation and vice versa.
- Ensure adequate vitamin C intake from fruit and vegetables to support gingival collagen integrity.
- Report bleeding gums, loose teeth, persistent bad breath, or mouth pain promptly – these are signs of active periodontal disease.
- Understand that treating dental disease is part of systemic microbiota care, not a separate consideration.
References
[144] Cani PD, Amar J, Iglesias MA et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007. Link
Cani and colleagues' 2007 Diabetes paper introduced the concept of 'metabolic endotoxemia' as a microbiota-driven trigger of obesity and insulin resistance. In mice, they show that a high-fat diet increases intestinal permeability and circulating lipopolysaccharide (LPS) levels, which activate TLR4-CD14 signalling and induce low-grade inflammation in adipose tissue, liver and muscle. Chronic subcutaneous LPS infusion in mice was sufficient to reproduce diet-induced obesity, insulin resistance and hepatic steatosis. CD14-knockout mice were protected. The paper established a mechanistic axis linking gut microbiota, barrier function and metabolic disease that has shaped subsequent obesity-microbiome research.
[254] Hajishengallis, G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015. Link
This review discusses how dysbiotic oral microbial communities drive periodontitis and inflammatory pathology at local and distant sites. The authors detail microbial immune subversion mechanisms that tip oral homeostasis to disease. Periodontitis emerges as a dysbiotic inflammatory disease with systemic implications, including links to cardiovascular and other chronic diseases. The findings frame periodontitis treatment as a strategy with potential systemic-health benefits.
[255] Tonetti MS, Van Dyke TE, and working group 1 of the joint EFP/AAP workshop. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop. J Clin Periodontol. 2013. Link
This consensus report evaluates the association between periodontitis and atherosclerotic cardiovascular disease (ACVD), assessing biological plausibility, epidemiology and intervention trial data. Periodontitis allows bacterial entry into the bloodstream, activating systemic inflammation that favours atheroma formation, maturation and exacerbation. The findings support periodontitis as a modifiable contributor to ACVD risk and recommend integration of periodontal screening into cardiovascular prevention strategies.